Global Targeted Radiopharmaceuticals Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our (LP Info Research) latest study, the global Targeted Radiopharmaceuticals market size was valued at US$ million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Targeted Radiopharmaceuticals is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Targeted Radiopharmaceuticals market. With recovery from influence of COVID-19 and the Russia-Ukraine War, Targeted Radiopharmaceuticals are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Targeted Radiopharmaceuticals. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Targeted Radiopharmaceuticals market.
Targeted radiopharmaceuticals are a type of medicinal product that combines a biologically active molecule (known as a ligand or targeting agent) with a radioactive isotope (radionuclide). These radiopharmaceuticals are designed to deliver radiation specifically to certain cells, tissues, or organs in the body, with the goal of achieving precise and localized treatment or imaging.
The concept of targeted radiopharmaceuticals is based on the idea of using the biological specificity of the ligand to selectively bind to receptors or antigens present on the target cells. Once the ligand has bound to its target, the radioactive component emits radiation that can be used for therapeutic purposes or imaging.There are two main categories of targeted radiopharmaceuticals: targeted therapeutic radiopharmaceuticals and targeted diagnostic radiopharmaceuticals.
Targeted radiopharmaceuticals offer several advantages over traditional treatments or imaging agents, including increased specificity, reduced damage to healthy tissues, and the potential for personalized medicine approaches based on the patient's specific disease characteristics. However, the development and use of targeted radiopharmaceuticals require careful consideration of the ligand's biological properties, radionuclide characteristics, and safety profiles to ensure effective and safe medical applications.
The radiopharmaceuticals market had been experiencing steady growth and significant interest due to the increasing use of nuclear medicine procedures for diagnostic and therapeutic purposes. Radiopharmaceuticals are essential tools in nuclear medicine, and they play a crucial role in diagnosing various diseases, such as cancer, cardiovascular conditions, and neurological disorders.
The radiopharmaceuticals market had been growing steadily over the years. Factors contributing to this growth include advancements in radiopharmaceutical development, rising prevalence of cancer and cardiovascular diseases, and an aging population that drives the demand for diagnostic procedures.
Key Features:
The report on Targeted Radiopharmaceuticals market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Targeted Radiopharmaceuticals market. It may include historical data, market segmentation by Type (e.g., Targeted Therapeutic Radiopharmaceuticals, Targeted Diagnostic Radiopharmaceuticals), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Targeted Radiopharmaceuticals market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Targeted Radiopharmaceuticals market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Targeted Radiopharmaceuticals industry. This include advancements in Targeted Radiopharmaceuticals technology, Targeted Radiopharmaceuticals new entrants, Targeted Radiopharmaceuticals new investment, and other innovations that are shaping the future of Targeted Radiopharmaceuticals.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Targeted Radiopharmaceuticals market. It includes factors influencing customer ' purchasing decisions, preferences for Targeted Radiopharmaceuticals product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Targeted Radiopharmaceuticals market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Targeted Radiopharmaceuticals market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Targeted Radiopharmaceuticals market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Targeted Radiopharmaceuticals industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Targeted Radiopharmaceuticals market.
Market Segmentation:
Targeted Radiopharmaceuticals market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Targeted Radiopharmaceuticals market?
What factors are driving Targeted Radiopharmaceuticals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Targeted Radiopharmaceuticals market opportunities vary by end market size?
How does Targeted Radiopharmaceuticals break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
According to our (LP Info Research) latest study, the global Targeted Radiopharmaceuticals market size was valued at US$ million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Targeted Radiopharmaceuticals is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Targeted Radiopharmaceuticals market. With recovery from influence of COVID-19 and the Russia-Ukraine War, Targeted Radiopharmaceuticals are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Targeted Radiopharmaceuticals. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Targeted Radiopharmaceuticals market.
Targeted radiopharmaceuticals are a type of medicinal product that combines a biologically active molecule (known as a ligand or targeting agent) with a radioactive isotope (radionuclide). These radiopharmaceuticals are designed to deliver radiation specifically to certain cells, tissues, or organs in the body, with the goal of achieving precise and localized treatment or imaging.
The concept of targeted radiopharmaceuticals is based on the idea of using the biological specificity of the ligand to selectively bind to receptors or antigens present on the target cells. Once the ligand has bound to its target, the radioactive component emits radiation that can be used for therapeutic purposes or imaging.There are two main categories of targeted radiopharmaceuticals: targeted therapeutic radiopharmaceuticals and targeted diagnostic radiopharmaceuticals.
Targeted radiopharmaceuticals offer several advantages over traditional treatments or imaging agents, including increased specificity, reduced damage to healthy tissues, and the potential for personalized medicine approaches based on the patient's specific disease characteristics. However, the development and use of targeted radiopharmaceuticals require careful consideration of the ligand's biological properties, radionuclide characteristics, and safety profiles to ensure effective and safe medical applications.
The radiopharmaceuticals market had been experiencing steady growth and significant interest due to the increasing use of nuclear medicine procedures for diagnostic and therapeutic purposes. Radiopharmaceuticals are essential tools in nuclear medicine, and they play a crucial role in diagnosing various diseases, such as cancer, cardiovascular conditions, and neurological disorders.
The radiopharmaceuticals market had been growing steadily over the years. Factors contributing to this growth include advancements in radiopharmaceutical development, rising prevalence of cancer and cardiovascular diseases, and an aging population that drives the demand for diagnostic procedures.
Key Features:
The report on Targeted Radiopharmaceuticals market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Targeted Radiopharmaceuticals market. It may include historical data, market segmentation by Type (e.g., Targeted Therapeutic Radiopharmaceuticals, Targeted Diagnostic Radiopharmaceuticals), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Targeted Radiopharmaceuticals market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Targeted Radiopharmaceuticals market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Targeted Radiopharmaceuticals industry. This include advancements in Targeted Radiopharmaceuticals technology, Targeted Radiopharmaceuticals new entrants, Targeted Radiopharmaceuticals new investment, and other innovations that are shaping the future of Targeted Radiopharmaceuticals.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Targeted Radiopharmaceuticals market. It includes factors influencing customer ' purchasing decisions, preferences for Targeted Radiopharmaceuticals product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Targeted Radiopharmaceuticals market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Targeted Radiopharmaceuticals market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Targeted Radiopharmaceuticals market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Targeted Radiopharmaceuticals industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Targeted Radiopharmaceuticals market.
Market Segmentation:
Targeted Radiopharmaceuticals market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Targeted Therapeutic Radiopharmaceuticals
- Targeted Diagnostic Radiopharmaceuticals
- Targeted Therapy
- Targeted Diagnosis
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Bayer
- Lantheus
- Institute for Radioelements (IRE)
- Radiomedix
- Curium Pharma
- Clarity Pharmaceuticals
- ROTOP
- Ratio Therapeutics
- Fusion Pharmaceuticals
- Perspective Therapeutics
- RayzeBio
- Alpha-9 Theranostics
- Radiopharm Theranostics
- Telix Pharmaceuticals
- Ariceum Therapeutics
- Aktis Oncology
- Navidea Biopharmaceuticals
- Nucleus RadioPharma
- SmartNuclide Biopharma
- TetraKit Technologies
What is the 10-year outlook for the global Targeted Radiopharmaceuticals market?
What factors are driving Targeted Radiopharmaceuticals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Targeted Radiopharmaceuticals market opportunities vary by end market size?
How does Targeted Radiopharmaceuticals break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeted Radiopharmaceuticals Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Targeted Radiopharmaceuticals by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Targeted Radiopharmaceuticals by Country/Region, 2018, 2022 & 2029
2.2 Targeted Radiopharmaceuticals Segment by Type
2.2.1 Targeted Therapeutic Radiopharmaceuticals
2.2.2 Targeted Diagnostic Radiopharmaceuticals
2.3 Targeted Radiopharmaceuticals Sales by Type
2.3.1 Global Targeted Radiopharmaceuticals Sales Market Share by Type (2018-2023)
2.3.2 Global Targeted Radiopharmaceuticals Revenue and Market Share by Type (2018-2023)
2.3.3 Global Targeted Radiopharmaceuticals Sale Price by Type (2018-2023)
2.4 Targeted Radiopharmaceuticals Segment by Application
2.4.1 Targeted Therapy
2.4.2 Targeted Diagnosis
2.5 Targeted Radiopharmaceuticals Sales by Application
2.5.1 Global Targeted Radiopharmaceuticals Sale Market Share by Application (2018-2023)
2.5.2 Global Targeted Radiopharmaceuticals Revenue and Market Share by Application (2018-2023)
2.5.3 Global Targeted Radiopharmaceuticals Sale Price by Application (2018-2023)
3 GLOBAL TARGETED RADIOPHARMACEUTICALS BY COMPANY
3.1 Global Targeted Radiopharmaceuticals Breakdown Data by Company
3.1.1 Global Targeted Radiopharmaceuticals Annual Sales by Company (2018-2023)
3.1.2 Global Targeted Radiopharmaceuticals Sales Market Share by Company (2018-2023)
3.2 Global Targeted Radiopharmaceuticals Annual Revenue by Company (2018-2023)
3.2.1 Global Targeted Radiopharmaceuticals Revenue by Company (2018-2023)
3.2.2 Global Targeted Radiopharmaceuticals Revenue Market Share by Company (2018-2023)
3.3 Global Targeted Radiopharmaceuticals Sale Price by Company
3.4 Key Manufacturers Targeted Radiopharmaceuticals Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Targeted Radiopharmaceuticals Product Location Distribution
3.4.2 Players Targeted Radiopharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TARGETED RADIOPHARMACEUTICALS BY GEOGRAPHIC REGION
4.1 World Historic Targeted Radiopharmaceuticals Market Size by Geographic Region (2018-2023)
4.1.1 Global Targeted Radiopharmaceuticals Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Targeted Radiopharmaceuticals Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Targeted Radiopharmaceuticals Market Size by Country/Region (2018-2023)
4.2.1 Global Targeted Radiopharmaceuticals Annual Sales by Country/Region (2018-2023)
4.2.2 Global Targeted Radiopharmaceuticals Annual Revenue by Country/Region (2018-2023)
4.3 Americas Targeted Radiopharmaceuticals Sales Growth
4.4 APAC Targeted Radiopharmaceuticals Sales Growth
4.5 Europe Targeted Radiopharmaceuticals Sales Growth
4.6 Middle East & Africa Targeted Radiopharmaceuticals Sales Growth
5 AMERICAS
5.1 Americas Targeted Radiopharmaceuticals Sales by Country
5.1.1 Americas Targeted Radiopharmaceuticals Sales by Country (2018-2023)
5.1.2 Americas Targeted Radiopharmaceuticals Revenue by Country (2018-2023)
5.2 Americas Targeted Radiopharmaceuticals Sales by Type
5.3 Americas Targeted Radiopharmaceuticals Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Radiopharmaceuticals Sales by Region
6.1.1 APAC Targeted Radiopharmaceuticals Sales by Region (2018-2023)
6.1.2 APAC Targeted Radiopharmaceuticals Revenue by Region (2018-2023)
6.2 APAC Targeted Radiopharmaceuticals Sales by Type
6.3 APAC Targeted Radiopharmaceuticals Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Targeted Radiopharmaceuticals by Country
7.1.1 Europe Targeted Radiopharmaceuticals Sales by Country (2018-2023)
7.1.2 Europe Targeted Radiopharmaceuticals Revenue by Country (2018-2023)
7.2 Europe Targeted Radiopharmaceuticals Sales by Type
7.3 Europe Targeted Radiopharmaceuticals Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeted Radiopharmaceuticals by Country
8.1.1 Middle East & Africa Targeted Radiopharmaceuticals Sales by Country (2018-2023)
8.1.2 Middle East & Africa Targeted Radiopharmaceuticals Revenue by Country (2018-2023)
8.2 Middle East & Africa Targeted Radiopharmaceuticals Sales by Type
8.3 Middle East & Africa Targeted Radiopharmaceuticals Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Targeted Radiopharmaceuticals
10.3 Manufacturing Process Analysis of Targeted Radiopharmaceuticals
10.4 Industry Chain Structure of Targeted Radiopharmaceuticals
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Targeted Radiopharmaceuticals Distributors
11.3 Targeted Radiopharmaceuticals Customer
12 WORLD FORECAST REVIEW FOR TARGETED RADIOPHARMACEUTICALS BY GEOGRAPHIC REGION
12.1 Global Targeted Radiopharmaceuticals Market Size Forecast by Region
12.1.1 Global Targeted Radiopharmaceuticals Forecast by Region (2024-2029)
12.1.2 Global Targeted Radiopharmaceuticals Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Targeted Radiopharmaceuticals Forecast by Type
12.7 Global Targeted Radiopharmaceuticals Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.1.3 Novartis Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.2.3 Bayer Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Lantheus
13.3.1 Lantheus Company Information
13.3.2 Lantheus Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.3.3 Lantheus Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Lantheus Main Business Overview
13.3.5 Lantheus Latest Developments
13.4 Institute for Radioelements (IRE)
13.4.1 Institute for Radioelements (IRE) Company Information
13.4.2 Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.4.3 Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Institute for Radioelements (IRE) Main Business Overview
13.4.5 Institute for Radioelements (IRE) Latest Developments
13.5 Radiomedix
13.5.1 Radiomedix Company Information
13.5.2 Radiomedix Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.5.3 Radiomedix Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Radiomedix Main Business Overview
13.5.5 Radiomedix Latest Developments
13.6 Curium Pharma
13.6.1 Curium Pharma Company Information
13.6.2 Curium Pharma Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.6.3 Curium Pharma Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Curium Pharma Main Business Overview
13.6.5 Curium Pharma Latest Developments
13.7 Clarity Pharmaceuticals
13.7.1 Clarity Pharmaceuticals Company Information
13.7.2 Clarity Pharmaceuticals Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.7.3 Clarity Pharmaceuticals Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Clarity Pharmaceuticals Main Business Overview
13.7.5 Clarity Pharmaceuticals Latest Developments
13.8 ROTOP
13.8.1 ROTOP Company Information
13.8.2 ROTOP Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.8.3 ROTOP Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 ROTOP Main Business Overview
13.8.5 ROTOP Latest Developments
13.9 Ratio Therapeutics
13.9.1 Ratio Therapeutics Company Information
13.9.2 Ratio Therapeutics Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.9.3 Ratio Therapeutics Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Ratio Therapeutics Main Business Overview
13.9.5 Ratio Therapeutics Latest Developments
13.10 Fusion Pharmaceuticals
13.10.1 Fusion Pharmaceuticals Company Information
13.10.2 Fusion Pharmaceuticals Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.10.3 Fusion Pharmaceuticals Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Fusion Pharmaceuticals Main Business Overview
13.10.5 Fusion Pharmaceuticals Latest Developments
13.11 Perspective Therapeutics
13.11.1 Perspective Therapeutics Company Information
13.11.2 Perspective Therapeutics Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.11.3 Perspective Therapeutics Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Perspective Therapeutics Main Business Overview
13.11.5 Perspective Therapeutics Latest Developments
13.12 RayzeBio
13.12.1 RayzeBio Company Information
13.12.2 RayzeBio Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.12.3 RayzeBio Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 RayzeBio Main Business Overview
13.12.5 RayzeBio Latest Developments
13.13 Alpha-9 Theranostics
13.13.1 Alpha-9 Theranostics Company Information
13.13.2 Alpha-9 Theranostics Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.13.3 Alpha-9 Theranostics Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Alpha-9 Theranostics Main Business Overview
13.13.5 Alpha-9 Theranostics Latest Developments
13.14 Radiopharm Theranostics
13.14.1 Radiopharm Theranostics Company Information
13.14.2 Radiopharm Theranostics Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.14.3 Radiopharm Theranostics Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Radiopharm Theranostics Main Business Overview
13.14.5 Radiopharm Theranostics Latest Developments
13.15 Telix Pharmaceuticals
13.15.1 Telix Pharmaceuticals Company Information
13.15.2 Telix Pharmaceuticals Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.15.3 Telix Pharmaceuticals Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Telix Pharmaceuticals Main Business Overview
13.15.5 Telix Pharmaceuticals Latest Developments
13.16 Ariceum Therapeutics
13.16.1 Ariceum Therapeutics Company Information
13.16.2 Ariceum Therapeutics Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.16.3 Ariceum Therapeutics Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Ariceum Therapeutics Main Business Overview
13.16.5 Ariceum Therapeutics Latest Developments
13.17 Aktis Oncology
13.17.1 Aktis Oncology Company Information
13.17.2 Aktis Oncology Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.17.3 Aktis Oncology Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Aktis Oncology Main Business Overview
13.17.5 Aktis Oncology Latest Developments
13.18 Navidea Biopharmaceuticals
13.18.1 Navidea Biopharmaceuticals Company Information
13.18.2 Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.18.3 Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Navidea Biopharmaceuticals Main Business Overview
13.18.5 Navidea Biopharmaceuticals Latest Developments
13.19 Nucleus RadioPharma
13.19.1 Nucleus RadioPharma Company Information
13.19.2 Nucleus RadioPharma Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.19.3 Nucleus RadioPharma Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Nucleus RadioPharma Main Business Overview
13.19.5 Nucleus RadioPharma Latest Developments
13.20 SmartNuclide Biopharma
13.20.1 SmartNuclide Biopharma Company Information
13.20.2 SmartNuclide Biopharma Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.20.3 SmartNuclide Biopharma Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 SmartNuclide Biopharma Main Business Overview
13.20.5 SmartNuclide Biopharma Latest Developments
13.21 TetraKit Technologies
13.21.1 TetraKit Technologies Company Information
13.21.2 TetraKit Technologies Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.21.3 TetraKit Technologies Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 TetraKit Technologies Main Business Overview
13.21.5 TetraKit Technologies Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeted Radiopharmaceuticals Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Targeted Radiopharmaceuticals by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Targeted Radiopharmaceuticals by Country/Region, 2018, 2022 & 2029
2.2 Targeted Radiopharmaceuticals Segment by Type
2.2.1 Targeted Therapeutic Radiopharmaceuticals
2.2.2 Targeted Diagnostic Radiopharmaceuticals
2.3 Targeted Radiopharmaceuticals Sales by Type
2.3.1 Global Targeted Radiopharmaceuticals Sales Market Share by Type (2018-2023)
2.3.2 Global Targeted Radiopharmaceuticals Revenue and Market Share by Type (2018-2023)
2.3.3 Global Targeted Radiopharmaceuticals Sale Price by Type (2018-2023)
2.4 Targeted Radiopharmaceuticals Segment by Application
2.4.1 Targeted Therapy
2.4.2 Targeted Diagnosis
2.5 Targeted Radiopharmaceuticals Sales by Application
2.5.1 Global Targeted Radiopharmaceuticals Sale Market Share by Application (2018-2023)
2.5.2 Global Targeted Radiopharmaceuticals Revenue and Market Share by Application (2018-2023)
2.5.3 Global Targeted Radiopharmaceuticals Sale Price by Application (2018-2023)
3 GLOBAL TARGETED RADIOPHARMACEUTICALS BY COMPANY
3.1 Global Targeted Radiopharmaceuticals Breakdown Data by Company
3.1.1 Global Targeted Radiopharmaceuticals Annual Sales by Company (2018-2023)
3.1.2 Global Targeted Radiopharmaceuticals Sales Market Share by Company (2018-2023)
3.2 Global Targeted Radiopharmaceuticals Annual Revenue by Company (2018-2023)
3.2.1 Global Targeted Radiopharmaceuticals Revenue by Company (2018-2023)
3.2.2 Global Targeted Radiopharmaceuticals Revenue Market Share by Company (2018-2023)
3.3 Global Targeted Radiopharmaceuticals Sale Price by Company
3.4 Key Manufacturers Targeted Radiopharmaceuticals Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Targeted Radiopharmaceuticals Product Location Distribution
3.4.2 Players Targeted Radiopharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TARGETED RADIOPHARMACEUTICALS BY GEOGRAPHIC REGION
4.1 World Historic Targeted Radiopharmaceuticals Market Size by Geographic Region (2018-2023)
4.1.1 Global Targeted Radiopharmaceuticals Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Targeted Radiopharmaceuticals Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Targeted Radiopharmaceuticals Market Size by Country/Region (2018-2023)
4.2.1 Global Targeted Radiopharmaceuticals Annual Sales by Country/Region (2018-2023)
4.2.2 Global Targeted Radiopharmaceuticals Annual Revenue by Country/Region (2018-2023)
4.3 Americas Targeted Radiopharmaceuticals Sales Growth
4.4 APAC Targeted Radiopharmaceuticals Sales Growth
4.5 Europe Targeted Radiopharmaceuticals Sales Growth
4.6 Middle East & Africa Targeted Radiopharmaceuticals Sales Growth
5 AMERICAS
5.1 Americas Targeted Radiopharmaceuticals Sales by Country
5.1.1 Americas Targeted Radiopharmaceuticals Sales by Country (2018-2023)
5.1.2 Americas Targeted Radiopharmaceuticals Revenue by Country (2018-2023)
5.2 Americas Targeted Radiopharmaceuticals Sales by Type
5.3 Americas Targeted Radiopharmaceuticals Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Radiopharmaceuticals Sales by Region
6.1.1 APAC Targeted Radiopharmaceuticals Sales by Region (2018-2023)
6.1.2 APAC Targeted Radiopharmaceuticals Revenue by Region (2018-2023)
6.2 APAC Targeted Radiopharmaceuticals Sales by Type
6.3 APAC Targeted Radiopharmaceuticals Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Targeted Radiopharmaceuticals by Country
7.1.1 Europe Targeted Radiopharmaceuticals Sales by Country (2018-2023)
7.1.2 Europe Targeted Radiopharmaceuticals Revenue by Country (2018-2023)
7.2 Europe Targeted Radiopharmaceuticals Sales by Type
7.3 Europe Targeted Radiopharmaceuticals Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeted Radiopharmaceuticals by Country
8.1.1 Middle East & Africa Targeted Radiopharmaceuticals Sales by Country (2018-2023)
8.1.2 Middle East & Africa Targeted Radiopharmaceuticals Revenue by Country (2018-2023)
8.2 Middle East & Africa Targeted Radiopharmaceuticals Sales by Type
8.3 Middle East & Africa Targeted Radiopharmaceuticals Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Targeted Radiopharmaceuticals
10.3 Manufacturing Process Analysis of Targeted Radiopharmaceuticals
10.4 Industry Chain Structure of Targeted Radiopharmaceuticals
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Targeted Radiopharmaceuticals Distributors
11.3 Targeted Radiopharmaceuticals Customer
12 WORLD FORECAST REVIEW FOR TARGETED RADIOPHARMACEUTICALS BY GEOGRAPHIC REGION
12.1 Global Targeted Radiopharmaceuticals Market Size Forecast by Region
12.1.1 Global Targeted Radiopharmaceuticals Forecast by Region (2024-2029)
12.1.2 Global Targeted Radiopharmaceuticals Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Targeted Radiopharmaceuticals Forecast by Type
12.7 Global Targeted Radiopharmaceuticals Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.1.3 Novartis Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.2.3 Bayer Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Lantheus
13.3.1 Lantheus Company Information
13.3.2 Lantheus Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.3.3 Lantheus Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Lantheus Main Business Overview
13.3.5 Lantheus Latest Developments
13.4 Institute for Radioelements (IRE)
13.4.1 Institute for Radioelements (IRE) Company Information
13.4.2 Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.4.3 Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Institute for Radioelements (IRE) Main Business Overview
13.4.5 Institute for Radioelements (IRE) Latest Developments
13.5 Radiomedix
13.5.1 Radiomedix Company Information
13.5.2 Radiomedix Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.5.3 Radiomedix Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Radiomedix Main Business Overview
13.5.5 Radiomedix Latest Developments
13.6 Curium Pharma
13.6.1 Curium Pharma Company Information
13.6.2 Curium Pharma Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.6.3 Curium Pharma Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Curium Pharma Main Business Overview
13.6.5 Curium Pharma Latest Developments
13.7 Clarity Pharmaceuticals
13.7.1 Clarity Pharmaceuticals Company Information
13.7.2 Clarity Pharmaceuticals Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.7.3 Clarity Pharmaceuticals Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Clarity Pharmaceuticals Main Business Overview
13.7.5 Clarity Pharmaceuticals Latest Developments
13.8 ROTOP
13.8.1 ROTOP Company Information
13.8.2 ROTOP Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.8.3 ROTOP Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 ROTOP Main Business Overview
13.8.5 ROTOP Latest Developments
13.9 Ratio Therapeutics
13.9.1 Ratio Therapeutics Company Information
13.9.2 Ratio Therapeutics Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.9.3 Ratio Therapeutics Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Ratio Therapeutics Main Business Overview
13.9.5 Ratio Therapeutics Latest Developments
13.10 Fusion Pharmaceuticals
13.10.1 Fusion Pharmaceuticals Company Information
13.10.2 Fusion Pharmaceuticals Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.10.3 Fusion Pharmaceuticals Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Fusion Pharmaceuticals Main Business Overview
13.10.5 Fusion Pharmaceuticals Latest Developments
13.11 Perspective Therapeutics
13.11.1 Perspective Therapeutics Company Information
13.11.2 Perspective Therapeutics Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.11.3 Perspective Therapeutics Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Perspective Therapeutics Main Business Overview
13.11.5 Perspective Therapeutics Latest Developments
13.12 RayzeBio
13.12.1 RayzeBio Company Information
13.12.2 RayzeBio Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.12.3 RayzeBio Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 RayzeBio Main Business Overview
13.12.5 RayzeBio Latest Developments
13.13 Alpha-9 Theranostics
13.13.1 Alpha-9 Theranostics Company Information
13.13.2 Alpha-9 Theranostics Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.13.3 Alpha-9 Theranostics Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Alpha-9 Theranostics Main Business Overview
13.13.5 Alpha-9 Theranostics Latest Developments
13.14 Radiopharm Theranostics
13.14.1 Radiopharm Theranostics Company Information
13.14.2 Radiopharm Theranostics Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.14.3 Radiopharm Theranostics Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Radiopharm Theranostics Main Business Overview
13.14.5 Radiopharm Theranostics Latest Developments
13.15 Telix Pharmaceuticals
13.15.1 Telix Pharmaceuticals Company Information
13.15.2 Telix Pharmaceuticals Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.15.3 Telix Pharmaceuticals Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Telix Pharmaceuticals Main Business Overview
13.15.5 Telix Pharmaceuticals Latest Developments
13.16 Ariceum Therapeutics
13.16.1 Ariceum Therapeutics Company Information
13.16.2 Ariceum Therapeutics Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.16.3 Ariceum Therapeutics Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Ariceum Therapeutics Main Business Overview
13.16.5 Ariceum Therapeutics Latest Developments
13.17 Aktis Oncology
13.17.1 Aktis Oncology Company Information
13.17.2 Aktis Oncology Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.17.3 Aktis Oncology Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Aktis Oncology Main Business Overview
13.17.5 Aktis Oncology Latest Developments
13.18 Navidea Biopharmaceuticals
13.18.1 Navidea Biopharmaceuticals Company Information
13.18.2 Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.18.3 Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Navidea Biopharmaceuticals Main Business Overview
13.18.5 Navidea Biopharmaceuticals Latest Developments
13.19 Nucleus RadioPharma
13.19.1 Nucleus RadioPharma Company Information
13.19.2 Nucleus RadioPharma Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.19.3 Nucleus RadioPharma Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Nucleus RadioPharma Main Business Overview
13.19.5 Nucleus RadioPharma Latest Developments
13.20 SmartNuclide Biopharma
13.20.1 SmartNuclide Biopharma Company Information
13.20.2 SmartNuclide Biopharma Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.20.3 SmartNuclide Biopharma Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 SmartNuclide Biopharma Main Business Overview
13.20.5 SmartNuclide Biopharma Latest Developments
13.21 TetraKit Technologies
13.21.1 TetraKit Technologies Company Information
13.21.2 TetraKit Technologies Targeted Radiopharmaceuticals Product Portfolios and Specifications
13.21.3 TetraKit Technologies Targeted Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 TetraKit Technologies Main Business Overview
13.21.5 TetraKit Technologies Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Targeted Radiopharmaceuticals Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Targeted Radiopharmaceuticals Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Targeted Therapeutic Radiopharmaceuticals
Table 4. Major Players of Targeted Diagnostic Radiopharmaceuticals
Table 5. Global Targeted Radiopharmaceuticals Sales by Type (2018-2023) & (K Units)
Table 6. Global Targeted Radiopharmaceuticals Sales Market Share by Type (2018-2023)
Table 7. Global Targeted Radiopharmaceuticals Revenue by Type (2018-2023) & ($ million)
Table 8. Global Targeted Radiopharmaceuticals Revenue Market Share by Type (2018-2023)
Table 9. Global Targeted Radiopharmaceuticals Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Targeted Radiopharmaceuticals Sales by Application (2018-2023) & (K Units)
Table 11. Global Targeted Radiopharmaceuticals Sales Market Share by Application (2018-2023)
Table 12. Global Targeted Radiopharmaceuticals Revenue by Application (2018-2023)
Table 13. Global Targeted Radiopharmaceuticals Revenue Market Share by Application (2018-2023)
Table 14. Global Targeted Radiopharmaceuticals Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Targeted Radiopharmaceuticals Sales by Company (2018-2023) & (K Units)
Table 16. Global Targeted Radiopharmaceuticals Sales Market Share by Company (2018-2023)
Table 17. Global Targeted Radiopharmaceuticals Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Targeted Radiopharmaceuticals Revenue Market Share by Company (2018-2023)
Table 19. Global Targeted Radiopharmaceuticals Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Targeted Radiopharmaceuticals Producing Area Distribution and Sales Area
Table 21. Players Targeted Radiopharmaceuticals Products Offered
Table 22. Targeted Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Targeted Radiopharmaceuticals Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Targeted Radiopharmaceuticals Sales Market Share Geographic Region (2018-2023)
Table 27. Global Targeted Radiopharmaceuticals Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Targeted Radiopharmaceuticals Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Targeted Radiopharmaceuticals Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Targeted Radiopharmaceuticals Sales Market Share by Country/Region (2018-2023)
Table 31. Global Targeted Radiopharmaceuticals Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Targeted Radiopharmaceuticals Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Targeted Radiopharmaceuticals Sales by Country (2018-2023) & (K Units)
Table 34. Americas Targeted Radiopharmaceuticals Sales Market Share by Country (2018-2023)
Table 35. Americas Targeted Radiopharmaceuticals Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Targeted Radiopharmaceuticals Revenue Market Share by Country (2018-2023)
Table 37. Americas Targeted Radiopharmaceuticals Sales by Type (2018-2023) & (K Units)
Table 38. Americas Targeted Radiopharmaceuticals Sales by Application (2018-2023) & (K Units)
Table 39. APAC Targeted Radiopharmaceuticals Sales by Region (2018-2023) & (K Units)
Table 40. APAC Targeted Radiopharmaceuticals Sales Market Share by Region (2018-2023)
Table 41. APAC Targeted Radiopharmaceuticals Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Targeted Radiopharmaceuticals Revenue Market Share by Region (2018-2023)
Table 43. APAC Targeted Radiopharmaceuticals Sales by Type (2018-2023) & (K Units)
Table 44. APAC Targeted Radiopharmaceuticals Sales by Application (2018-2023) & (K Units)
Table 45. Europe Targeted Radiopharmaceuticals Sales by Country (2018-2023) & (K Units)
Table 46. Europe Targeted Radiopharmaceuticals Sales Market Share by Country (2018-2023)
Table 47. Europe Targeted Radiopharmaceuticals Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Targeted Radiopharmaceuticals Revenue Market Share by Country (2018-2023)
Table 49. Europe Targeted Radiopharmaceuticals Sales by Type (2018-2023) & (K Units)
Table 50. Europe Targeted Radiopharmaceuticals Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Targeted Radiopharmaceuticals Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Targeted Radiopharmaceuticals Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Targeted Radiopharmaceuticals Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Targeted Radiopharmaceuticals Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Targeted Radiopharmaceuticals Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Targeted Radiopharmaceuticals Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Targeted Radiopharmaceuticals
Table 58. Key Market Challenges & Risks of Targeted Radiopharmaceuticals
Table 59. Key Industry Trends of Targeted Radiopharmaceuticals
Table 60. Targeted Radiopharmaceuticals Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Targeted Radiopharmaceuticals Distributors List
Table 63. Targeted Radiopharmaceuticals Customer List
Table 64. Global Targeted Radiopharmaceuticals Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Targeted Radiopharmaceuticals Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Targeted Radiopharmaceuticals Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Targeted Radiopharmaceuticals Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Targeted Radiopharmaceuticals Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Targeted Radiopharmaceuticals Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Targeted Radiopharmaceuticals Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Targeted Radiopharmaceuticals Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Targeted Radiopharmaceuticals Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Targeted Radiopharmaceuticals Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Targeted Radiopharmaceuticals Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Targeted Radiopharmaceuticals Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Targeted Radiopharmaceuticals Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Targeted Radiopharmaceuticals Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Novartis Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 79. Novartis Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 80. Novartis Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Novartis Main Business
Table 82. Novartis Latest Developments
Table 83. Bayer Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 84. Bayer Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 85. Bayer Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Bayer Main Business
Table 87. Bayer Latest Developments
Table 88. Lantheus Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 89. Lantheus Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 90. Lantheus Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Lantheus Main Business
Table 92. Lantheus Latest Developments
Table 93. Institute for Radioelements (IRE) Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 94. Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 95. Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Institute for Radioelements (IRE) Main Business
Table 97. Institute for Radioelements (IRE) Latest Developments
Table 98. Radiomedix Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 99. Radiomedix Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 100. Radiomedix Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Radiomedix Main Business
Table 102. Radiomedix Latest Developments
Table 103. Curium Pharma Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 104. Curium Pharma Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 105. Curium Pharma Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Curium Pharma Main Business
Table 107. Curium Pharma Latest Developments
Table 108. Clarity Pharmaceuticals Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 109. Clarity Pharmaceuticals Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 110. Clarity Pharmaceuticals Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Clarity Pharmaceuticals Main Business
Table 112. Clarity Pharmaceuticals Latest Developments
Table 113. ROTOP Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 114. ROTOP Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 115. ROTOP Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. ROTOP Main Business
Table 117. ROTOP Latest Developments
Table 118. Ratio Therapeutics Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 119. Ratio Therapeutics Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 120. Ratio Therapeutics Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Ratio Therapeutics Main Business
Table 122. Ratio Therapeutics Latest Developments
Table 123. Fusion Pharmaceuticals Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 124. Fusion Pharmaceuticals Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 125. Fusion Pharmaceuticals Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Fusion Pharmaceuticals Main Business
Table 127. Fusion Pharmaceuticals Latest Developments
Table 128. Perspective Therapeutics Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 129. Perspective Therapeutics Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 130. Perspective Therapeutics Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Perspective Therapeutics Main Business
Table 132. Perspective Therapeutics Latest Developments
Table 133. RayzeBio Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 134. RayzeBio Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 135. RayzeBio Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. RayzeBio Main Business
Table 137. RayzeBio Latest Developments
Table 138. Alpha-9 Theranostics Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 139. Alpha-9 Theranostics Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 140. Alpha-9 Theranostics Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Alpha-9 Theranostics Main Business
Table 142. Alpha-9 Theranostics Latest Developments
Table 143. Radiopharm Theranostics Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 144. Radiopharm Theranostics Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 145. Radiopharm Theranostics Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Radiopharm Theranostics Main Business
Table 147. Radiopharm Theranostics Latest Developments
Table 148. Telix Pharmaceuticals Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 149. Telix Pharmaceuticals Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 150. Telix Pharmaceuticals Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Telix Pharmaceuticals Main Business
Table 152. Telix Pharmaceuticals Latest Developments
Table 153. Ariceum Therapeutics Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 154. Ariceum Therapeutics Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 155. Ariceum Therapeutics Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Ariceum Therapeutics Main Business
Table 157. Ariceum Therapeutics Latest Developments
Table 158. Aktis Oncology Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 159. Aktis Oncology Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 160. Aktis Oncology Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Aktis Oncology Main Business
Table 162. Aktis Oncology Latest Developments
Table 163. Navidea Biopharmaceuticals Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 164. Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 165. Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Navidea Biopharmaceuticals Main Business
Table 167. Navidea Biopharmaceuticals Latest Developments
Table 168. Nucleus RadioPharma Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 169. Nucleus RadioPharma Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 170. Nucleus RadioPharma Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 171. Nucleus RadioPharma Main Business
Table 172. Nucleus RadioPharma Latest Developments
Table 173. SmartNuclide Biopharma Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 174. SmartNuclide Biopharma Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 175. SmartNuclide Biopharma Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 176. SmartNuclide Biopharma Main Business
Table 177. SmartNuclide Biopharma Latest Developments
Table 178. TetraKit Technologies Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 179. TetraKit Technologies Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 180. TetraKit Technologies Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 181. TetraKit Technologies Main Business
Table 182. TetraKit Technologies Latest Developments
Table 1. Targeted Radiopharmaceuticals Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Targeted Radiopharmaceuticals Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Targeted Therapeutic Radiopharmaceuticals
Table 4. Major Players of Targeted Diagnostic Radiopharmaceuticals
Table 5. Global Targeted Radiopharmaceuticals Sales by Type (2018-2023) & (K Units)
Table 6. Global Targeted Radiopharmaceuticals Sales Market Share by Type (2018-2023)
Table 7. Global Targeted Radiopharmaceuticals Revenue by Type (2018-2023) & ($ million)
Table 8. Global Targeted Radiopharmaceuticals Revenue Market Share by Type (2018-2023)
Table 9. Global Targeted Radiopharmaceuticals Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Targeted Radiopharmaceuticals Sales by Application (2018-2023) & (K Units)
Table 11. Global Targeted Radiopharmaceuticals Sales Market Share by Application (2018-2023)
Table 12. Global Targeted Radiopharmaceuticals Revenue by Application (2018-2023)
Table 13. Global Targeted Radiopharmaceuticals Revenue Market Share by Application (2018-2023)
Table 14. Global Targeted Radiopharmaceuticals Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Targeted Radiopharmaceuticals Sales by Company (2018-2023) & (K Units)
Table 16. Global Targeted Radiopharmaceuticals Sales Market Share by Company (2018-2023)
Table 17. Global Targeted Radiopharmaceuticals Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Targeted Radiopharmaceuticals Revenue Market Share by Company (2018-2023)
Table 19. Global Targeted Radiopharmaceuticals Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Targeted Radiopharmaceuticals Producing Area Distribution and Sales Area
Table 21. Players Targeted Radiopharmaceuticals Products Offered
Table 22. Targeted Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Targeted Radiopharmaceuticals Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Targeted Radiopharmaceuticals Sales Market Share Geographic Region (2018-2023)
Table 27. Global Targeted Radiopharmaceuticals Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Targeted Radiopharmaceuticals Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Targeted Radiopharmaceuticals Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Targeted Radiopharmaceuticals Sales Market Share by Country/Region (2018-2023)
Table 31. Global Targeted Radiopharmaceuticals Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Targeted Radiopharmaceuticals Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Targeted Radiopharmaceuticals Sales by Country (2018-2023) & (K Units)
Table 34. Americas Targeted Radiopharmaceuticals Sales Market Share by Country (2018-2023)
Table 35. Americas Targeted Radiopharmaceuticals Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Targeted Radiopharmaceuticals Revenue Market Share by Country (2018-2023)
Table 37. Americas Targeted Radiopharmaceuticals Sales by Type (2018-2023) & (K Units)
Table 38. Americas Targeted Radiopharmaceuticals Sales by Application (2018-2023) & (K Units)
Table 39. APAC Targeted Radiopharmaceuticals Sales by Region (2018-2023) & (K Units)
Table 40. APAC Targeted Radiopharmaceuticals Sales Market Share by Region (2018-2023)
Table 41. APAC Targeted Radiopharmaceuticals Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Targeted Radiopharmaceuticals Revenue Market Share by Region (2018-2023)
Table 43. APAC Targeted Radiopharmaceuticals Sales by Type (2018-2023) & (K Units)
Table 44. APAC Targeted Radiopharmaceuticals Sales by Application (2018-2023) & (K Units)
Table 45. Europe Targeted Radiopharmaceuticals Sales by Country (2018-2023) & (K Units)
Table 46. Europe Targeted Radiopharmaceuticals Sales Market Share by Country (2018-2023)
Table 47. Europe Targeted Radiopharmaceuticals Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Targeted Radiopharmaceuticals Revenue Market Share by Country (2018-2023)
Table 49. Europe Targeted Radiopharmaceuticals Sales by Type (2018-2023) & (K Units)
Table 50. Europe Targeted Radiopharmaceuticals Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Targeted Radiopharmaceuticals Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Targeted Radiopharmaceuticals Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Targeted Radiopharmaceuticals Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Targeted Radiopharmaceuticals Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Targeted Radiopharmaceuticals Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Targeted Radiopharmaceuticals Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Targeted Radiopharmaceuticals
Table 58. Key Market Challenges & Risks of Targeted Radiopharmaceuticals
Table 59. Key Industry Trends of Targeted Radiopharmaceuticals
Table 60. Targeted Radiopharmaceuticals Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Targeted Radiopharmaceuticals Distributors List
Table 63. Targeted Radiopharmaceuticals Customer List
Table 64. Global Targeted Radiopharmaceuticals Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Targeted Radiopharmaceuticals Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Targeted Radiopharmaceuticals Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Targeted Radiopharmaceuticals Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Targeted Radiopharmaceuticals Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Targeted Radiopharmaceuticals Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Targeted Radiopharmaceuticals Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Targeted Radiopharmaceuticals Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Targeted Radiopharmaceuticals Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Targeted Radiopharmaceuticals Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Targeted Radiopharmaceuticals Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Targeted Radiopharmaceuticals Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Targeted Radiopharmaceuticals Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Targeted Radiopharmaceuticals Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Novartis Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 79. Novartis Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 80. Novartis Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Novartis Main Business
Table 82. Novartis Latest Developments
Table 83. Bayer Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 84. Bayer Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 85. Bayer Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Bayer Main Business
Table 87. Bayer Latest Developments
Table 88. Lantheus Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 89. Lantheus Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 90. Lantheus Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Lantheus Main Business
Table 92. Lantheus Latest Developments
Table 93. Institute for Radioelements (IRE) Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 94. Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 95. Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Institute for Radioelements (IRE) Main Business
Table 97. Institute for Radioelements (IRE) Latest Developments
Table 98. Radiomedix Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 99. Radiomedix Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 100. Radiomedix Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Radiomedix Main Business
Table 102. Radiomedix Latest Developments
Table 103. Curium Pharma Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 104. Curium Pharma Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 105. Curium Pharma Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Curium Pharma Main Business
Table 107. Curium Pharma Latest Developments
Table 108. Clarity Pharmaceuticals Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 109. Clarity Pharmaceuticals Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 110. Clarity Pharmaceuticals Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Clarity Pharmaceuticals Main Business
Table 112. Clarity Pharmaceuticals Latest Developments
Table 113. ROTOP Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 114. ROTOP Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 115. ROTOP Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. ROTOP Main Business
Table 117. ROTOP Latest Developments
Table 118. Ratio Therapeutics Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 119. Ratio Therapeutics Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 120. Ratio Therapeutics Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Ratio Therapeutics Main Business
Table 122. Ratio Therapeutics Latest Developments
Table 123. Fusion Pharmaceuticals Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 124. Fusion Pharmaceuticals Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 125. Fusion Pharmaceuticals Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Fusion Pharmaceuticals Main Business
Table 127. Fusion Pharmaceuticals Latest Developments
Table 128. Perspective Therapeutics Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 129. Perspective Therapeutics Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 130. Perspective Therapeutics Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Perspective Therapeutics Main Business
Table 132. Perspective Therapeutics Latest Developments
Table 133. RayzeBio Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 134. RayzeBio Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 135. RayzeBio Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. RayzeBio Main Business
Table 137. RayzeBio Latest Developments
Table 138. Alpha-9 Theranostics Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 139. Alpha-9 Theranostics Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 140. Alpha-9 Theranostics Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Alpha-9 Theranostics Main Business
Table 142. Alpha-9 Theranostics Latest Developments
Table 143. Radiopharm Theranostics Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 144. Radiopharm Theranostics Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 145. Radiopharm Theranostics Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Radiopharm Theranostics Main Business
Table 147. Radiopharm Theranostics Latest Developments
Table 148. Telix Pharmaceuticals Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 149. Telix Pharmaceuticals Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 150. Telix Pharmaceuticals Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Telix Pharmaceuticals Main Business
Table 152. Telix Pharmaceuticals Latest Developments
Table 153. Ariceum Therapeutics Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 154. Ariceum Therapeutics Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 155. Ariceum Therapeutics Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Ariceum Therapeutics Main Business
Table 157. Ariceum Therapeutics Latest Developments
Table 158. Aktis Oncology Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 159. Aktis Oncology Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 160. Aktis Oncology Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Aktis Oncology Main Business
Table 162. Aktis Oncology Latest Developments
Table 163. Navidea Biopharmaceuticals Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 164. Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 165. Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Navidea Biopharmaceuticals Main Business
Table 167. Navidea Biopharmaceuticals Latest Developments
Table 168. Nucleus RadioPharma Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 169. Nucleus RadioPharma Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 170. Nucleus RadioPharma Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 171. Nucleus RadioPharma Main Business
Table 172. Nucleus RadioPharma Latest Developments
Table 173. SmartNuclide Biopharma Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 174. SmartNuclide Biopharma Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 175. SmartNuclide Biopharma Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 176. SmartNuclide Biopharma Main Business
Table 177. SmartNuclide Biopharma Latest Developments
Table 178. TetraKit Technologies Basic Information, Targeted Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 179. TetraKit Technologies Targeted Radiopharmaceuticals Product Portfolios and Specifications
Table 180. TetraKit Technologies Targeted Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 181. TetraKit Technologies Main Business
Table 182. TetraKit Technologies Latest Developments
LIST OF FIGURES
Figure 1. Picture of Targeted Radiopharmaceuticals
Figure 2. Targeted Radiopharmaceuticals Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Targeted Radiopharmaceuticals Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Targeted Radiopharmaceuticals Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Targeted Radiopharmaceuticals Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Targeted Therapeutic Radiopharmaceuticals
Figure 10. Product Picture of Targeted Diagnostic Radiopharmaceuticals
Figure 11. Global Targeted Radiopharmaceuticals Sales Market Share by Type in 2022
Figure 12. Global Targeted Radiopharmaceuticals Revenue Market Share by Type (2018-2023)
Figure 13. Targeted Radiopharmaceuticals Consumed in Targeted Therapy
Figure 14. Global Targeted Radiopharmaceuticals Market: Targeted Therapy (2018-2023) & (K Units)
Figure 15. Targeted Radiopharmaceuticals Consumed in Targeted Diagnosis
Figure 16. Global Targeted Radiopharmaceuticals Market: Targeted Diagnosis (2018-2023) & (K Units)
Figure 17. Global Targeted Radiopharmaceuticals Sales Market Share by Application (2022)
Figure 18. Global Targeted Radiopharmaceuticals Revenue Market Share by Application in 2022
Figure 19. Targeted Radiopharmaceuticals Sales Market by Company in 2022 (K Units)
Figure 20. Global Targeted Radiopharmaceuticals Sales Market Share by Company in 2022
Figure 21. Targeted Radiopharmaceuticals Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Targeted Radiopharmaceuticals Revenue Market Share by Company in 2022
Figure 23. Global Targeted Radiopharmaceuticals Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Targeted Radiopharmaceuticals Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Targeted Radiopharmaceuticals Sales 2018-2023 (K Units)
Figure 26. Americas Targeted Radiopharmaceuticals Revenue 2018-2023 ($ Millions)
Figure 27. APAC Targeted Radiopharmaceuticals Sales 2018-2023 (K Units)
Figure 28. APAC Targeted Radiopharmaceuticals Revenue 2018-2023 ($ Millions)
Figure 29. Europe Targeted Radiopharmaceuticals Sales 2018-2023 (K Units)
Figure 30. Europe Targeted Radiopharmaceuticals Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Targeted Radiopharmaceuticals Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Targeted Radiopharmaceuticals Revenue 2018-2023 ($ Millions)
Figure 33. Americas Targeted Radiopharmaceuticals Sales Market Share by Country in 2022
Figure 34. Americas Targeted Radiopharmaceuticals Revenue Market Share by Country in 2022
Figure 35. Americas Targeted Radiopharmaceuticals Sales Market Share by Type (2018-2023)
Figure 36. Americas Targeted Radiopharmaceuticals Sales Market Share by Application (2018-2023)
Figure 37. United States Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Targeted Radiopharmaceuticals Sales Market Share by Region in 2022
Figure 42. APAC Targeted Radiopharmaceuticals Revenue Market Share by Regions in 2022
Figure 43. APAC Targeted Radiopharmaceuticals Sales Market Share by Type (2018-2023)
Figure 44. APAC Targeted Radiopharmaceuticals Sales Market Share by Application (2018-2023)
Figure 45. China Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Targeted Radiopharmaceuticals Sales Market Share by Country in 2022
Figure 53. Europe Targeted Radiopharmaceuticals Revenue Market Share by Country in 2022
Figure 54. Europe Targeted Radiopharmaceuticals Sales Market Share by Type (2018-2023)
Figure 55. Europe Targeted Radiopharmaceuticals Sales Market Share by Application (2018-2023)
Figure 56. Germany Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Targeted Radiopharmaceuticals Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Targeted Radiopharmaceuticals Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Targeted Radiopharmaceuticals Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Targeted Radiopharmaceuticals Sales Market Share by Application (2018-2023)
Figure 65. Egypt Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Targeted Radiopharmaceuticals in 2022
Figure 71. Manufacturing Process Analysis of Targeted Radiopharmaceuticals
Figure 72. Industry Chain Structure of Targeted Radiopharmaceuticals
Figure 73. Channels of Distribution
Figure 74. Global Targeted Radiopharmaceuticals Sales Market Forecast by Region (2024-2029)
Figure 75. Global Targeted Radiopharmaceuticals Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Targeted Radiopharmaceuticals Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Targeted Radiopharmaceuticals Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Targeted Radiopharmaceuticals Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Targeted Radiopharmaceuticals Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Targeted Radiopharmaceuticals
Figure 2. Targeted Radiopharmaceuticals Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Targeted Radiopharmaceuticals Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Targeted Radiopharmaceuticals Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Targeted Radiopharmaceuticals Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Targeted Therapeutic Radiopharmaceuticals
Figure 10. Product Picture of Targeted Diagnostic Radiopharmaceuticals
Figure 11. Global Targeted Radiopharmaceuticals Sales Market Share by Type in 2022
Figure 12. Global Targeted Radiopharmaceuticals Revenue Market Share by Type (2018-2023)
Figure 13. Targeted Radiopharmaceuticals Consumed in Targeted Therapy
Figure 14. Global Targeted Radiopharmaceuticals Market: Targeted Therapy (2018-2023) & (K Units)
Figure 15. Targeted Radiopharmaceuticals Consumed in Targeted Diagnosis
Figure 16. Global Targeted Radiopharmaceuticals Market: Targeted Diagnosis (2018-2023) & (K Units)
Figure 17. Global Targeted Radiopharmaceuticals Sales Market Share by Application (2022)
Figure 18. Global Targeted Radiopharmaceuticals Revenue Market Share by Application in 2022
Figure 19. Targeted Radiopharmaceuticals Sales Market by Company in 2022 (K Units)
Figure 20. Global Targeted Radiopharmaceuticals Sales Market Share by Company in 2022
Figure 21. Targeted Radiopharmaceuticals Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Targeted Radiopharmaceuticals Revenue Market Share by Company in 2022
Figure 23. Global Targeted Radiopharmaceuticals Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Targeted Radiopharmaceuticals Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Targeted Radiopharmaceuticals Sales 2018-2023 (K Units)
Figure 26. Americas Targeted Radiopharmaceuticals Revenue 2018-2023 ($ Millions)
Figure 27. APAC Targeted Radiopharmaceuticals Sales 2018-2023 (K Units)
Figure 28. APAC Targeted Radiopharmaceuticals Revenue 2018-2023 ($ Millions)
Figure 29. Europe Targeted Radiopharmaceuticals Sales 2018-2023 (K Units)
Figure 30. Europe Targeted Radiopharmaceuticals Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Targeted Radiopharmaceuticals Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Targeted Radiopharmaceuticals Revenue 2018-2023 ($ Millions)
Figure 33. Americas Targeted Radiopharmaceuticals Sales Market Share by Country in 2022
Figure 34. Americas Targeted Radiopharmaceuticals Revenue Market Share by Country in 2022
Figure 35. Americas Targeted Radiopharmaceuticals Sales Market Share by Type (2018-2023)
Figure 36. Americas Targeted Radiopharmaceuticals Sales Market Share by Application (2018-2023)
Figure 37. United States Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Targeted Radiopharmaceuticals Sales Market Share by Region in 2022
Figure 42. APAC Targeted Radiopharmaceuticals Revenue Market Share by Regions in 2022
Figure 43. APAC Targeted Radiopharmaceuticals Sales Market Share by Type (2018-2023)
Figure 44. APAC Targeted Radiopharmaceuticals Sales Market Share by Application (2018-2023)
Figure 45. China Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Targeted Radiopharmaceuticals Sales Market Share by Country in 2022
Figure 53. Europe Targeted Radiopharmaceuticals Revenue Market Share by Country in 2022
Figure 54. Europe Targeted Radiopharmaceuticals Sales Market Share by Type (2018-2023)
Figure 55. Europe Targeted Radiopharmaceuticals Sales Market Share by Application (2018-2023)
Figure 56. Germany Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Targeted Radiopharmaceuticals Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Targeted Radiopharmaceuticals Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Targeted Radiopharmaceuticals Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Targeted Radiopharmaceuticals Sales Market Share by Application (2018-2023)
Figure 65. Egypt Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Targeted Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Targeted Radiopharmaceuticals in 2022
Figure 71. Manufacturing Process Analysis of Targeted Radiopharmaceuticals
Figure 72. Industry Chain Structure of Targeted Radiopharmaceuticals
Figure 73. Channels of Distribution
Figure 74. Global Targeted Radiopharmaceuticals Sales Market Forecast by Region (2024-2029)
Figure 75. Global Targeted Radiopharmaceuticals Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Targeted Radiopharmaceuticals Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Targeted Radiopharmaceuticals Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Targeted Radiopharmaceuticals Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Targeted Radiopharmaceuticals Revenue Market Share Forecast by Application (2024-2029)
